Loading…
How has fundholding in Northern Ireland affected prescribing patterns? A longitudinal study
Abstract Objective: To compare prescribing patterns in general practices before and after the introduction of fundholding in April 1993 to determine whether fundholding changed prescribing patterns among practices that joined the scheme. Design: Analysis of prescribing data from the Drug Utilisation...
Saved in:
Published in: | BMJ 1997-07, Vol.315 (7101), p.166-170 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 170 |
container_issue | 7101 |
container_start_page | 166 |
container_title | BMJ |
container_volume | 315 |
creator | Rafferty, Thérèse Wilson-Davis, Keith McGavock, Hugh |
description | Abstract Objective: To compare prescribing patterns in general practices before and after the introduction of fundholding in April 1993 to determine whether fundholding changed prescribing patterns among practices that joined the scheme. Design: Analysis of prescribing data from the Drug Utilisation Research Unit's database for all practices in Northern Ireland during April 1989 to March 1996. Setting: Northern Ireland. Subjects: 23 first wave fundholders, 34 second wave fundholders, 9 third wave fundholders, and 268 non-fundholders. Main outcome measures: Prescribing costs per 1000 patients, prescription items per 1000 patients, average cost per item, and rate of generic prescribing. Results: Prescribing costs and frequency increased in all groups throughout the study. Among the fundholders the rate of increase in costs after fundholding was significantly lower than among non-fundholders. The rate of increase in cost per item fell, coinciding with a significant increase in the rate of generic prescribing. However, with regard to first wave fundholders, their yearly increase in costs in their third year as fundholders (1995-6) was similar to that of the non-fundholders. The earlier practices that joined the scheme seemed to differ in some important respects from those that joined later. Conclusions: After fundholders joined the fundholding scheme their patterns of prescribing changed compared with those of non-fundholders: the rate of increase in costs fell and there was a significant rise in the rate of generic prescribing. Key messages The effects of fundholding on prescribing costs have been disputed Fundholders in Northern Ireland contained the rate of increase in prescribing costs more effectively than non-fundholders Fundholders increased their rate of generic prescribing by an average of 13% in the first year of fundholding The incentive to make further savings may have diminished after two years of fundholding |
format | article |
fullrecord | <record><control><sourceid>jstor_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2127119</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>25175198</jstor_id><sourcerecordid>25175198</sourcerecordid><originalsourceid>FETCH-LOGICAL-b426t-3749e8c8fef625f913938caeadce5b4267c1827dd71d2b552fc2d0e37199a2ca3</originalsourceid><addsrcrecordid>eNqFkV2LEzEUhgdR1rLuTxACgjcykJNMJsmNshZ115bVC_XGi5DJRzt1OukmGXf335vSUj9uvErgec7LeTmPqhk0raiZoPRxNcOSyVoAFU-ri5Q2GGNCuZAtO6vOJGHAGjGrvl-FO7TWCflptOsw2H5coX5ENyHmtYsjuo5u0KNF2ntnsrNoF10yse_24k7nXKT0Bl2iIYyrPk8lQA8olc_Ds-qJ10NyF8f3vPr6_t2X-VW9_PThen65rLuGtLmmvJFOGOGdbwnzEqikwminrXFsr3ADgnBrOVjSMUa8IRY7ykFKTYym59XrQ-5u6rauTI056kHtYr_V8UEF3au_ydiv1Sr8VAQIB5Al4OUxIIbbyaWstn0ybijFXZiS4hK4xLQp4ot_xE2YYimcFHDOWSsBaLHwwTIxpBSdP60CWBWhVd12oygwxQGDgrYtI8__rHAaON7pN9-kHOIJF8oZyD2vD7xP2d2fuI4_VMspZ-rm21yxxefm7WK5UB-L_-rg7zf573a_AJ7qtrA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1777569113</pqid></control><display><type>article</type><title>How has fundholding in Northern Ireland affected prescribing patterns? A longitudinal study</title><source>JSTOR Archival Journals and Primary Sources Collection</source><source>BMJ Publishing</source><creator>Rafferty, Thérèse ; Wilson-Davis, Keith ; McGavock, Hugh</creator><creatorcontrib>Rafferty, Thérèse ; Wilson-Davis, Keith ; McGavock, Hugh</creatorcontrib><description>Abstract Objective: To compare prescribing patterns in general practices before and after the introduction of fundholding in April 1993 to determine whether fundholding changed prescribing patterns among practices that joined the scheme. Design: Analysis of prescribing data from the Drug Utilisation Research Unit's database for all practices in Northern Ireland during April 1989 to March 1996. Setting: Northern Ireland. Subjects: 23 first wave fundholders, 34 second wave fundholders, 9 third wave fundholders, and 268 non-fundholders. Main outcome measures: Prescribing costs per 1000 patients, prescription items per 1000 patients, average cost per item, and rate of generic prescribing. Results: Prescribing costs and frequency increased in all groups throughout the study. Among the fundholders the rate of increase in costs after fundholding was significantly lower than among non-fundholders. The rate of increase in cost per item fell, coinciding with a significant increase in the rate of generic prescribing. However, with regard to first wave fundholders, their yearly increase in costs in their third year as fundholders (1995-6) was similar to that of the non-fundholders. The earlier practices that joined the scheme seemed to differ in some important respects from those that joined later. Conclusions: After fundholders joined the fundholding scheme their patterns of prescribing changed compared with those of non-fundholders: the rate of increase in costs fell and there was a significant rise in the rate of generic prescribing. Key messages The effects of fundholding on prescribing costs have been disputed Fundholders in Northern Ireland contained the rate of increase in prescribing costs more effectively than non-fundholders Fundholders increased their rate of generic prescribing by an average of 13% in the first year of fundholding The incentive to make further savings may have diminished after two years of fundholding</description><identifier>ISSN: 0959-8138</identifier><identifier>EISSN: 1468-5833</identifier><identifier>EISSN: 1756-1833</identifier><identifier>PMID: 9251548</identifier><language>eng</language><publisher>England: British Medical Journal Publishing Group</publisher><subject>Brand name drugs ; Cost efficiency ; Cost estimates ; Cost incentives ; Cost savings ; Drug Costs ; Drug prescriptions ; Drug Prescriptions - economics ; Drugs, Generic - economics ; Family Practice - economics ; Family Practice - trends ; Financial budgets ; Financial Management ; General practice ; Humans ; Longitudinal Studies ; Northern Ireland ; Practice Patterns, Physicians' - economics ; Practice Patterns, Physicians' - trends ; Prescription drugs ; Savings motives</subject><ispartof>BMJ, 1997-07, Vol.315 (7101), p.166-170</ispartof><rights>1997 BMJ Publishing Group Ltd.</rights><rights>Copyright 1997 British Medical Journal</rights><rights>Copyright: 1997 (c) 1997 BMJ Publishing Group Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://bmj.com/content/315/7101/166.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://bmj.com/content/315/7101/166.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>113,230,314,780,784,885,58237,58470,77365,77366</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9251548$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rafferty, Thérèse</creatorcontrib><creatorcontrib>Wilson-Davis, Keith</creatorcontrib><creatorcontrib>McGavock, Hugh</creatorcontrib><title>How has fundholding in Northern Ireland affected prescribing patterns? A longitudinal study</title><title>BMJ</title><addtitle>BMJ</addtitle><description>Abstract Objective: To compare prescribing patterns in general practices before and after the introduction of fundholding in April 1993 to determine whether fundholding changed prescribing patterns among practices that joined the scheme. Design: Analysis of prescribing data from the Drug Utilisation Research Unit's database for all practices in Northern Ireland during April 1989 to March 1996. Setting: Northern Ireland. Subjects: 23 first wave fundholders, 34 second wave fundholders, 9 third wave fundholders, and 268 non-fundholders. Main outcome measures: Prescribing costs per 1000 patients, prescription items per 1000 patients, average cost per item, and rate of generic prescribing. Results: Prescribing costs and frequency increased in all groups throughout the study. Among the fundholders the rate of increase in costs after fundholding was significantly lower than among non-fundholders. The rate of increase in cost per item fell, coinciding with a significant increase in the rate of generic prescribing. However, with regard to first wave fundholders, their yearly increase in costs in their third year as fundholders (1995-6) was similar to that of the non-fundholders. The earlier practices that joined the scheme seemed to differ in some important respects from those that joined later. Conclusions: After fundholders joined the fundholding scheme their patterns of prescribing changed compared with those of non-fundholders: the rate of increase in costs fell and there was a significant rise in the rate of generic prescribing. Key messages The effects of fundholding on prescribing costs have been disputed Fundholders in Northern Ireland contained the rate of increase in prescribing costs more effectively than non-fundholders Fundholders increased their rate of generic prescribing by an average of 13% in the first year of fundholding The incentive to make further savings may have diminished after two years of fundholding</description><subject>Brand name drugs</subject><subject>Cost efficiency</subject><subject>Cost estimates</subject><subject>Cost incentives</subject><subject>Cost savings</subject><subject>Drug Costs</subject><subject>Drug prescriptions</subject><subject>Drug Prescriptions - economics</subject><subject>Drugs, Generic - economics</subject><subject>Family Practice - economics</subject><subject>Family Practice - trends</subject><subject>Financial budgets</subject><subject>Financial Management</subject><subject>General practice</subject><subject>Humans</subject><subject>Longitudinal Studies</subject><subject>Northern Ireland</subject><subject>Practice Patterns, Physicians' - economics</subject><subject>Practice Patterns, Physicians' - trends</subject><subject>Prescription drugs</subject><subject>Savings motives</subject><issn>0959-8138</issn><issn>1468-5833</issn><issn>1756-1833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNqFkV2LEzEUhgdR1rLuTxACgjcykJNMJsmNshZ115bVC_XGi5DJRzt1OukmGXf335vSUj9uvErgec7LeTmPqhk0raiZoPRxNcOSyVoAFU-ri5Q2GGNCuZAtO6vOJGHAGjGrvl-FO7TWCflptOsw2H5coX5ENyHmtYsjuo5u0KNF2ntnsrNoF10yse_24k7nXKT0Bl2iIYyrPk8lQA8olc_Ds-qJ10NyF8f3vPr6_t2X-VW9_PThen65rLuGtLmmvJFOGOGdbwnzEqikwminrXFsr3ADgnBrOVjSMUa8IRY7ykFKTYym59XrQ-5u6rauTI056kHtYr_V8UEF3au_ydiv1Sr8VAQIB5Al4OUxIIbbyaWstn0ybijFXZiS4hK4xLQp4ot_xE2YYimcFHDOWSsBaLHwwTIxpBSdP60CWBWhVd12oygwxQGDgrYtI8__rHAaON7pN9-kHOIJF8oZyD2vD7xP2d2fuI4_VMspZ-rm21yxxefm7WK5UB-L_-rg7zf573a_AJ7qtrA</recordid><startdate>19970719</startdate><enddate>19970719</enddate><creator>Rafferty, Thérèse</creator><creator>Wilson-Davis, Keith</creator><creator>McGavock, Hugh</creator><general>British Medical Journal Publishing Group</general><general>British Medical Association</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9.</scope><scope>LK8</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19970719</creationdate><title>How has fundholding in Northern Ireland affected prescribing patterns? A longitudinal study</title><author>Rafferty, Thérèse ; Wilson-Davis, Keith ; McGavock, Hugh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b426t-3749e8c8fef625f913938caeadce5b4267c1827dd71d2b552fc2d0e37199a2ca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Brand name drugs</topic><topic>Cost efficiency</topic><topic>Cost estimates</topic><topic>Cost incentives</topic><topic>Cost savings</topic><topic>Drug Costs</topic><topic>Drug prescriptions</topic><topic>Drug Prescriptions - economics</topic><topic>Drugs, Generic - economics</topic><topic>Family Practice - economics</topic><topic>Family Practice - trends</topic><topic>Financial budgets</topic><topic>Financial Management</topic><topic>General practice</topic><topic>Humans</topic><topic>Longitudinal Studies</topic><topic>Northern Ireland</topic><topic>Practice Patterns, Physicians' - economics</topic><topic>Practice Patterns, Physicians' - trends</topic><topic>Prescription drugs</topic><topic>Savings motives</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rafferty, Thérèse</creatorcontrib><creatorcontrib>Wilson-Davis, Keith</creatorcontrib><creatorcontrib>McGavock, Hugh</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>ProQuest research library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMJ</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rafferty, Thérèse</au><au>Wilson-Davis, Keith</au><au>McGavock, Hugh</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>How has fundholding in Northern Ireland affected prescribing patterns? A longitudinal study</atitle><jtitle>BMJ</jtitle><addtitle>BMJ</addtitle><date>1997-07-19</date><risdate>1997</risdate><volume>315</volume><issue>7101</issue><spage>166</spage><epage>170</epage><pages>166-170</pages><issn>0959-8138</issn><eissn>1468-5833</eissn><eissn>1756-1833</eissn><abstract>Abstract Objective: To compare prescribing patterns in general practices before and after the introduction of fundholding in April 1993 to determine whether fundholding changed prescribing patterns among practices that joined the scheme. Design: Analysis of prescribing data from the Drug Utilisation Research Unit's database for all practices in Northern Ireland during April 1989 to March 1996. Setting: Northern Ireland. Subjects: 23 first wave fundholders, 34 second wave fundholders, 9 third wave fundholders, and 268 non-fundholders. Main outcome measures: Prescribing costs per 1000 patients, prescription items per 1000 patients, average cost per item, and rate of generic prescribing. Results: Prescribing costs and frequency increased in all groups throughout the study. Among the fundholders the rate of increase in costs after fundholding was significantly lower than among non-fundholders. The rate of increase in cost per item fell, coinciding with a significant increase in the rate of generic prescribing. However, with regard to first wave fundholders, their yearly increase in costs in their third year as fundholders (1995-6) was similar to that of the non-fundholders. The earlier practices that joined the scheme seemed to differ in some important respects from those that joined later. Conclusions: After fundholders joined the fundholding scheme their patterns of prescribing changed compared with those of non-fundholders: the rate of increase in costs fell and there was a significant rise in the rate of generic prescribing. Key messages The effects of fundholding on prescribing costs have been disputed Fundholders in Northern Ireland contained the rate of increase in prescribing costs more effectively than non-fundholders Fundholders increased their rate of generic prescribing by an average of 13% in the first year of fundholding The incentive to make further savings may have diminished after two years of fundholding</abstract><cop>England</cop><pub>British Medical Journal Publishing Group</pub><pmid>9251548</pmid><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0959-8138 |
ispartof | BMJ, 1997-07, Vol.315 (7101), p.166-170 |
issn | 0959-8138 1468-5833 1756-1833 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2127119 |
source | JSTOR Archival Journals and Primary Sources Collection; BMJ Publishing |
subjects | Brand name drugs Cost efficiency Cost estimates Cost incentives Cost savings Drug Costs Drug prescriptions Drug Prescriptions - economics Drugs, Generic - economics Family Practice - economics Family Practice - trends Financial budgets Financial Management General practice Humans Longitudinal Studies Northern Ireland Practice Patterns, Physicians' - economics Practice Patterns, Physicians' - trends Prescription drugs Savings motives |
title | How has fundholding in Northern Ireland affected prescribing patterns? A longitudinal study |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T07%3A59%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=How%20has%20fundholding%20in%20Northern%20Ireland%20affected%20prescribing%20patterns?%20A%20longitudinal%20study&rft.jtitle=BMJ&rft.au=Rafferty,%20Th%C3%A9r%C3%A8se&rft.date=1997-07-19&rft.volume=315&rft.issue=7101&rft.spage=166&rft.epage=170&rft.pages=166-170&rft.issn=0959-8138&rft.eissn=1468-5833&rft_id=info:doi/&rft_dat=%3Cjstor_pubme%3E25175198%3C/jstor_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b426t-3749e8c8fef625f913938caeadce5b4267c1827dd71d2b552fc2d0e37199a2ca3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1777569113&rft_id=info:pmid/9251548&rft_jstor_id=25175198&rfr_iscdi=true |